N-arylsulfonyl-3-aminoalkoxyindoles

Details for Australian Patent Application No. 2003285759 (hide)

Owner Suven Life Sciences Limited

Inventors Jasti, Venkateswarlu; Kambhampati, Rama Sastri; Ramakrishna, Venkata Satya Nirogi; Rao, Venkata Satya Veerabhadra Vadlamudi; Shirsath, Vikas Shreekrishna

Agent Griffith Hack

Pub. Number AU-B-2003285759

PCT Number PCT/IN2003/0003

PCT Pub. Number WO2004/048328

Priority 883/MAS/2002 28.11.02 IN

Filing date 25 November 2003

Wipo publication date 18 June 2004

Acceptance publication date 28 January 2010

International Classifications

C07D 209/00 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/429 (2006.01) - condensed with heterocyclic ring systems

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/36 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 883/MAS/2002 28.11.02 IN

22 July 2004 Application Open to Public Inspection

  Published as AU-B-2003285759

28 January 2010 Application Accepted

  Published as AU-B-2003285759

27 May 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003285760-CLEANING AGENT COMPOSITION, CLEANING AND PRODUCTION METHODS FOR SEMICONDUCTOR WAFER, AND SEMICONDUCTOR WAFER

2003285758-A VEGF VARIANT THAT LACKS VEGFR-1 BINDING ACTIVITY AND ITS USE IN PROMOTION OF REENDOTHELIZATION AND PREVENTION OF IN-STENT RESTENOSIS